For citations:
Yakovlev SV, Suvorova MP, Bykov AO, Zhuravel SV, Popugaev KA, Kulagina LY, Ochakovskaya IN, Fedorova MG, Pribytkova OV, Zateyshchikova AA, Malkova OG, Malorodova TN, Nekaeva ES, Ogonkin NG, Strezh YA, Sychev IN, Tazieva OI, Fominykh SG. An Open-Label, Multicenter, Observational Study of The Effectiveness of The Cefepime/Sulbactam Antibiotic (Maxictam®-AF) In Patients With Intra Abdominal Infection, Nosocomial Pneumonia or Ventilator-Associated Pneumonia (Study MAXI-2019). Antibiotiki i Khimioterapiya = Antibiotics and Chemotherapy. 2020;65(11-12):49-58. (In Russ.) https://doi.org/10.37489/0235-2990-2020-65-11-12-49-58
Email this article 